Mallinckrodt Hosp Drug Patent Portfolio

Mallinckrodt Hosp owns 2 orange book drugs protected by 55 US patents Given below is the list of Mallinckrodt Hosp's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9770570 Apparatus and method for monitoring nitric oxide delivery 03 Nov, 2036
Active
US9770570 Apparatus and method for monitoring nitric oxide delivery 03 May, 2036
Active
US9279794 Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide 19 Aug, 2034
Active
US9279794 Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide 19 Feb, 2034
Active
US9399012 Reduced dose intravenous acetaminophen 11 Mar, 2032
Active
US9399012 Reduced dose intravenous acetaminophen 11 Sep, 2031
Active
US8291904 Gas delivery device and system 06 Jul, 2031
Active
US8573209 Gas delivery device and system 06 Jul, 2031
Active
US8573210 Nitric oxide delivery device 06 Jul, 2031
Active
US8776794 Nitric oxide delivery device 06 Jul, 2031
Active
US8776795 Gas delivery device and system 06 Jul, 2031
Active
US9265911 Gas delivery device and system 06 Jul, 2031
Active
US9295802 Gas delivery device and system 06 Jul, 2031
Active
US9408993 Nitric oxide delivery device 06 Jul, 2031
Active
US8291904 Gas delivery device and system 06 Jan, 2031
Active
US8573209 Gas delivery device and system 06 Jan, 2031
Active
US8573210 Nitric oxide delivery device 06 Jan, 2031
Active
US8776794 Nitric oxide delivery device 06 Jan, 2031
Active
US8776795 Gas delivery device and system 06 Jan, 2031
Active
US9265911 Gas delivery device and system 06 Jan, 2031
Active
US9295802 Gas delivery device and system 06 Jan, 2031
Active
US9408993 Nitric oxide delivery device 06 Jan, 2031
Active
US8282966 Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide 30 Dec, 2029
Active
US8293284 Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide 30 Dec, 2029
Active
US8431163 Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas 30 Dec, 2029
Active
US8795741 Methods for treating patients who are candidates for inhaled nitric oxide treatment 30 Dec, 2029
Active
US8846112 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation 30 Dec, 2029
Active
US11931377 Methods of administering inhaled nitric oxide gas 03 Dec, 2029
Active
US8282966 Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide 30 Jun, 2029
Active
US8293284 Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide 30 Jun, 2029
Active
US8431163 Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas 30 Jun, 2029
Active
US8795741 Methods for treating patients who are candidates for inhaled nitric oxide treatment 30 Jun, 2029
Active
US8846112 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation 30 Jun, 2029
Active
US11931377 Methods of administering inhaled nitric oxide gas 03 Jun, 2029
Active
US9610265 Reduced dose intravenous acetaminophen 13 May, 2029
Active
US9987238 Reduced dose intravenous acetaminophen 13 May, 2029
Active
US10383834 Reduced dose intravenous acetaminophen 13 Nov, 2028
Active
US9610265 Reduced dose intravenous acetaminophen 13 Nov, 2028
Active
US9987238 Reduced dose intravenous acetaminophen 13 Nov, 2028
Active
US6992218 Method for obtaining aqueous formulations of oxidation-sensitive active principles 06 Dec, 2021 Expired
US6992218 Method for obtaining aqueous formulations of oxidation-sensitive active principles 06 Jun, 2021 Expired
US6028222 Stable liquid paracetamol compositions, and method for preparing same 05 Feb, 2018 Expired
US6125846 Purge system for nitric oxide administration apparatus 16 Nov, 2017 Expired
US6028222 Stable liquid paracetamol compositions, and method for preparing same 05 Aug, 2017 Expired
US5732693 Pause control of nitric oxide therapy 13 Jun, 2017 Expired
US5752504 System for monitoring therapy during calibration 13 Jun, 2017 Expired
US6125846 Purge system for nitric oxide administration apparatus 16 May, 2017 Expired
US5732693 Pause control of nitric oxide therapy 13 Dec, 2016 Expired
US5752504 System for monitoring therapy during calibration 13 Dec, 2016 Expired
US5558083 Nitric oxide delivery system 22 May, 2014 Expired
US5558083 Nitric oxide delivery system 22 Nov, 2013 Expired
US5485827 Methods and devices for treating plumonary vasoconstriction and asthma 23 Jul, 2013 Expired
US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma 23 Jul, 2013 Expired
US5485827 Methods and devices for treating plumonary vasoconstriction and asthma 23 Jan, 2013 Expired
US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma 23 Jan, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Mallinckrodt Hosp.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 23 Apr, 2024 US8291904
Payment of Maintenance Fee, 8th Year, Large Entity 09 Feb, 2024 US9408993
Payment of Maintenance Fee, 8th Year, Large Entity 26 Jan, 2024 US9399012
Payment of Maintenance Fee, 8th Year, Large Entity 29 Sep, 2023 US9295802 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 08 Sep, 2023 US9279794 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 23 Aug, 2023 US9265911 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 20 Feb, 2023 US10383834
Payment of Maintenance Fee, 8th Yr, Small Entity 30 Mar, 2022 US8846112
Payment of Maintenance Fee, 8th Year, Large Entity 07 Feb, 2022 US8795741
Payment of Maintenance Fee, 8th Yr, Small Entity 17 Jan, 2022 US8776795
Payment of Maintenance Fee, 8th Yr, Small Entity 17 Jan, 2022 US8776794
Payment of Maintenance Fee, 4th Year, Large Entity 06 Dec, 2021 US9987238
Payment of Maintenance Fee, 8th Year, Large Entity 05 May, 2021 US8573210 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 05 May, 2021 US8573209
Payment of Maintenance Fee, 4th Year, Large Entity 30 Sep, 2020 US9770570


Mallinckrodt Hosp's Drug Patent Litigations

Mallinckrodt Hosp's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 05, 2015, against patent number US8795741. The petitioner Praxair Distribution, Inc., challenged the validity of this patent, with INO Therapeutics LLC as the respondent. Click below to track the latest information on how companies are challenging Mallinckrodt Hosp's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8282966 March, 2016 Terminated-Denied
(22 Sep, 2016)
Mallinckrodt Hospital Products IP Ltd. Praxair Distribution, Inc.
US8293284 March, 2016 Terminated-Denied
(22 Sep, 2016)
Mallinckrodt Hospital Products IP Ltd. Praxair Distribution, Inc.
US8431163 March, 2016 Terminated-Denied
(22 Sep, 2016)
Mallinckrodt Hospital Products IP Ltd. Praxair Distribution, Inc.
US8795741 March, 2016 Terminated-Denied
(22 Sep, 2016)
Mallinckrodt Hospital Products IP Ltd. Praxair Distribution, Inc.
US8776795 March, 2015 FWD Entered
(19 Sep, 2016)
INO Therapeutics LLC Praxair Distribution, Inc.
US8573209 March, 2015 FWD Entered
(15 Sep, 2016)
INO THERAPEUTICS LLC Praxair Distribution, Inc.
US8573210 March, 2015 FWD Entered
(15 Sep, 2016)
INO Therapeutics LLC Praxair Distribution, Inc.
US8776794 March, 2015 FWD Entered
(14 Sep, 2016)
INO Therapeutics LLC Praxair Distribution, Inc.
US8291904 March, 2015 FWD Entered
(12 Sep, 2016)
INO Therapeutics LLC Praxair Distribution, Inc.
US8846112 March, 2016 Terminated-Denied
(25 Aug, 2016)
Mallinckrodt Hospital Products IP Ltd. Praxair Distribution, Inc.
US8846112 January, 2015 FWD Entered
(07 Jul, 2016)
INO THERAPEUTICS LLC Praxair Distribution, Inc.
US8282966 January, 2015 Terminated-Denied
(29 Jul, 2015)
INO Therapeutics LLC Praxair Distribution, Inc.
US8293284 January, 2015 Terminated-Denied
(29 Jul, 2015)
INO Therapeutics LLC Praxair Distribution, Inc.
US8431163 January, 2015 Terminated-Denied
(29 Jul, 2015)
INO THERAPEUTICS LLC Praxair Distribution, Inc.
US8795741 January, 2015 Terminated-Denied
(29 Jul, 2015)
INO Therapeutics LLC Praxair Distribution, Inc.


Mallinckrodt Hosp's Family Patents

Mallinckrodt Hosp drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 34.5% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Mallinckrodt Hosp Drug List

Given below is the complete list of Mallinckrodt Hosp's drugs and the patents protecting them.


1. Inomax

Inomax is protected by 44 patents, out of which 12 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9770570
(Pediatric)
Apparatus and method for monitoring nitric oxide delivery 03 Nov, 2036
(12 years from now)
Active
US9770570 Apparatus and method for monitoring nitric oxide delivery 03 May, 2036
(11 years from now)
Active
US9279794
(Pediatric)
Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide 19 Aug, 2034
(9 years from now)
Active
US9279794 Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide 19 Feb, 2034
(9 years from now)
Active
US8291904
(Pediatric)
Gas delivery device and system 06 Jul, 2031
(6 years from now)
Active
US8573209
(Pediatric)
Gas delivery device and system 06 Jul, 2031
(6 years from now)
Active
US8573210
(Pediatric)
Nitric oxide delivery device 06 Jul, 2031
(6 years from now)
Active
US8776794
(Pediatric)
Nitric oxide delivery device 06 Jul, 2031
(6 years from now)
Active
US8776795
(Pediatric)
Gas delivery device and system 06 Jul, 2031
(6 years from now)
Active
US9265911
(Pediatric)
Gas delivery device and system 06 Jul, 2031
(6 years from now)
Active
US9295802
(Pediatric)
Gas delivery device and system 06 Jul, 2031
(6 years from now)
Active
US9408993
(Pediatric)
Nitric oxide delivery device 06 Jul, 2031
(6 years from now)
Active
US8291904 Gas delivery device and system 06 Jan, 2031
(6 years from now)
Active
US8573209 Gas delivery device and system 06 Jan, 2031
(6 years from now)
Active
US8573210 Nitric oxide delivery device 06 Jan, 2031
(6 years from now)
Active
US8776794 Nitric oxide delivery device 06 Jan, 2031
(6 years from now)
Active
US8776795 Gas delivery device and system 06 Jan, 2031
(6 years from now)
Active
US9265911 Gas delivery device and system 06 Jan, 2031
(6 years from now)
Active
US9295802 Gas delivery device and system 06 Jan, 2031
(6 years from now)
Active
US9408993 Nitric oxide delivery device 06 Jan, 2031
(6 years from now)
Active
US8282966
(Pediatric)
Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide 30 Dec, 2029
(5 years from now)
Active
US8293284
(Pediatric)
Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide 30 Dec, 2029
(5 years from now)
Active
US8431163
(Pediatric)
Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas 30 Dec, 2029
(5 years from now)
Active
US8795741
(Pediatric)
Methods for treating patients who are candidates for inhaled nitric oxide treatment 30 Dec, 2029
(5 years from now)
Active
US8846112
(Pediatric)
Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation 30 Dec, 2029
(5 years from now)
Active
US11931377
(Pediatric)
Methods of administering inhaled nitric oxide gas 03 Dec, 2029
(5 years from now)
Active
US8282966 Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide 30 Jun, 2029
(4 years from now)
Active
US8293284 Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide 30 Jun, 2029
(4 years from now)
Active
US8431163 Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas 30 Jun, 2029
(4 years from now)
Active
US8795741 Methods for treating patients who are candidates for inhaled nitric oxide treatment 30 Jun, 2029
(4 years from now)
Active
US8846112 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation 30 Jun, 2029
(4 years from now)
Active
US11931377 Methods of administering inhaled nitric oxide gas 03 Jun, 2029
(4 years from now)
Active
US6125846
(Pediatric)
Purge system for nitric oxide administration apparatus 16 Nov, 2017
(6 years ago)
Expired
US5732693
(Pediatric)
Pause control of nitric oxide therapy 13 Jun, 2017
(7 years ago)
Expired
US5752504
(Pediatric)
System for monitoring therapy during calibration 13 Jun, 2017
(7 years ago)
Expired
US6125846 Purge system for nitric oxide administration apparatus 16 May, 2017
(7 years ago)
Expired
US5732693 Pause control of nitric oxide therapy 13 Dec, 2016
(7 years ago)
Expired
US5752504 System for monitoring therapy during calibration 13 Dec, 2016
(7 years ago)
Expired
US5558083
(Pediatric)
Nitric oxide delivery system 22 May, 2014
(10 years ago)
Expired
US5558083 Nitric oxide delivery system 22 Nov, 2013
(10 years ago)
Expired
US5485827
(Pediatric)
Methods and devices for treating plumonary vasoconstriction and asthma 23 Jul, 2013
(11 years ago)
Expired
US5873359
(Pediatric)
Methods and devices for treating pulmonary vasoconstriction and asthma 23 Jul, 2013
(11 years ago)
Expired
US5485827 Methods and devices for treating plumonary vasoconstriction and asthma 23 Jan, 2013
(11 years ago)
Expired
US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma 23 Jan, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inomax's drug page


2. Ofirmev

Ofirmev is protected by 11 patents, out of which 4 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9399012
(Pediatric)
Reduced dose intravenous acetaminophen 11 Mar, 2032
(7 years from now)
Active
US9399012 Reduced dose intravenous acetaminophen 11 Sep, 2031
(6 years from now)
Active
US9610265
(Pediatric)
Reduced dose intravenous acetaminophen 13 May, 2029
(4 years from now)
Active
US9987238
(Pediatric)
Reduced dose intravenous acetaminophen 13 May, 2029
(4 years from now)
Active
US10383834 Reduced dose intravenous acetaminophen 13 Nov, 2028
(4 years from now)
Active
US9610265 Reduced dose intravenous acetaminophen 13 Nov, 2028
(4 years from now)
Active
US9987238 Reduced dose intravenous acetaminophen 13 Nov, 2028
(4 years from now)
Active
US6992218
(Pediatric)
Method for obtaining aqueous formulations of oxidation-sensitive active principles 06 Dec, 2021
(2 years ago)
Expired
US6992218 Method for obtaining aqueous formulations of oxidation-sensitive active principles 06 Jun, 2021
(3 years ago)
Expired
US6028222
(Pediatric)
Stable liquid paracetamol compositions, and method for preparing same 05 Feb, 2018
(6 years ago)
Expired
US6028222 Stable liquid paracetamol compositions, and method for preparing same 05 Aug, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ofirmev's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List